Trial NCT03180294

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

This phase II randomized trial studies how well bupropion hydrochloride works in improving sexual desire in women with breast or gynecological cancer. Bupropion hydrochloride may work by boosting sexual desire, energy, or motivation without causing intolerable or undesirable side effects.

Intervention

Bupropion Hydrochloride, Placebo

Condition

Breast Carcinoma, Cervical Carcinoma, Ovarian Carcinoma, Postmenopausal, Uterine Corpus Cancer, Vaginal Carcinoma, Vulvar Carcinoma

Investigators

Frank J. Brescia, Jeffrey K. Giguere, Bret E. Friday, Keren Sturtz, Jessica A. Thomes Pepin, J. R. Liu, Matthew L. Ryan, Elizabeth L. Dickson Michelson, Benjamin T. Marchello, Ramey D. Littell, Augusto C. Ochoa, Timothy D. Moore, Gregory A. Masters, Thomas E. Lad, Pavan S. Reddy, Howard M. Gross, Jay W. Carlson, Radhika P. Gogoi, Jonathan A. Polikoff, John A. Keech, Mark A. Hoffman, Kenneth N. Sumida, Robert J. Behrens, Brandon M. Barney, Howard A. Zaren, Donald B. Wender, Maria C. Bell, Pratima Chalasani, Albert S. DeNittis, Carolyn Y. Muller, Robert D. Siegel, James E. Radford, Demet Gokalp Yasar, Bryan A. Faller, Kathleen J. Yost, Alexander Menter, William P. Fusselman, Rakesh Gaur, Richard L. Deming, Vinay K. Gudena, Amanda R. Hathaway, Nagesh H. Jayaram

See list of participating sites